Skip to main content
Caplight Logo









Interfere

Interfere

Private
New York City, New YorkEnterprise Softwarehttps://interfere.com/

Last Round

Seed

Oct 1, 2025

Est. Valuation

$1.79M

Total Funding Raised

$20.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Interfere is a software company that develops a self-healing layer for the internet designed to automatically detect, triage, and fix software bugs.

Sector

Enterprise Software

Verticals

DevOps & Containers, Incident Response, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

self-healing softwareautomated bug fixingautomated remediationauto-remediationAIOpsroot cause analysisself-fixing codeautonomous softwareincident response automationproduction debuggingapplication stabilityreal-time diagnosticsdeveloper toolsobservability

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Interfere Comparables

Compare Interfere with similar companies based on industry and business-model similarity.

Interfere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Superlog
89%
bugstack
82%
Sazabi
79%

Interfere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2025
SeedJul 1, 2025
SeedJun 1, 2025
AcceleratorMar 1, 2025

Key People

Founding team and executive leadership

Luke Shiels

Founder CEO

Founding Team

Interfere Investors

Notable investors and investment history

Interfere investors
InvestorRounds
Andreessen HorowitzSeed
Hit ForgeSeed
Threshold VenturesSeed
Greylock PartnersSeed
Roble VenturesSeed
Vercel VenturesSeed
Y CombinatorSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 37% MoM, reaching 44.5K.

  • Apr 19, 2026

    Monthly visitors increased 1274% MoM to 32.5K.

Interfere Filings

Explore SEC and related filing metadata, where available.

Interfere filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Interfere's valuation, stock price, and market status.

Is Interfere a public or private company?

Interfere is a private company.

What is the current stock price of Interfere?

Interfere is a private company with no public stock price. No recent secondary market data is available.

How much is Interfere worth (valuation)?

Valuation information for Interfere is not publicly available.

Can I buy Interfere stock?

Interfere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Interfere's last funding round?

Interfere's most recent funding round was Seed on July 1, 2025.

Who are the main investors in Interfere?

Key investors in Interfere include Andreessen Horowitz, Hit Forge, Threshold Ventures, Greylock Partners, Roble Ventures.

Will Interfere IPO soon?

No public IPO plans have been announced for Interfere.

How can I track Interfere secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Interfere's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range7
Year Founded2025
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?